FDA reports new deaths with diabetes drug Byetta

August 18th, 2008 in Medicine & Health / Medications

(AP) -- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be reported despite earlier government warnings.

---

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

---